CureVac Dropping One COVID-19 Vaccine, Shifts Focus To Second GSK-Partnered Candidate

Reuters (10/12, Szymanska, Burger) reports CureVac “said on Tuesday it will give up on its first-generation COVID-19 vaccine candidate and instead focus on collaborating with GSK to develop improved mRNA vaccine technology.” The company will “abandon its...